Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Prev Alzheimers Dis ; 11(2): 514-524, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-38374758

RESUMEN

BACKGROUND: Unsupervised online cognitive assessments have demonstrated promise as an efficient and scalable approach for evaluating cognition in aging, and Alzheimer's disease and related dementias. OBJECTIVES: The aim of this study was to evaluate the feasibility, usability, and construct validity of the Paired Associates Learning task from the Cambridge Neuropsychological Test Automated Battery® in adults enrolled in the Brain Health Registry. DESIGN, SETTING, PARTICIPANTS, MEASUREMENTS: The Paired Associates Learning task was administered to Brain Health Registry participants in a remote, unsupervised, online setting. In this cross-sectional analysis, we 1) evaluated construct validity by analyzing associations between Paired Associates Learning performance and additional participant registry data, including demographics, self- and study partner-reported subjective cognitive change (Everyday Cognition scale), self-reported memory concern, and depressive symptom severity (Patient Health Questionnaire-9) using multivariable linear regression models; 2) determined the predictive value of Paired Associates Learning and other registry variables for identifying participants who self-report Mild Cognitive Impairment by employing multivariable binomial logistic regressions and calculating the area under the receiver operator curve; 3) investigated feasibility by looking at task completion rates and statistically comparing characteristics of task completers and non-completers; and 4) evaluated usability in terms of participant requests for support from BHR related to the assessment. RESULTS: In terms of construct validity, in participants who took the Paired Associates Learning for the first time (N=14,528), worse performance was associated with being older, being male, lower educational attainment, higher levels of self- and study partner-reported decline, more self-reported memory concerns, greater depressive symptom severity, and self-report of Mild Cognitive Impairment. Paired Associates Learning performance and Brain Health Registry variables together identified those with self-reported Mild Cognitive Impairment with moderate accuracy (areas under the curve: 0.66-0.68). In terms of feasibility, in a sub-sample of 29,176 participants who had the opportunity to complete Paired Associates Learning for the first time in the registry, 14,417 started the task. 11,647 (80.9% of those who started) completed the task. Compared to those who did not complete the task at their first opportunity, those who completed were older, had more years of education, more likely to self-identify as White, less likely to self-identify as Latino, less likely to have a subjective memory concern, and more likely to report a family history of Alzheimer's disease. In terms of usability, out of 8,395 received requests for support from BHR staff via email, 4.4% (n=374) were related to PAL. Of those, 82% were related to technical difficulties. CONCLUSIONS: Our findings support moderate feasibility, good usability, and construct validity of cross-sectional Paired Associates Learning in an unsupervised online registry, but also highlight the need to make the assessment more inclusive and accessible to individuals from ethnoculturally and socioeconomically diverse communities. A future, improved version could be a scalable, efficient method to assess cognition in many different settings, including clinical trials, observational studies, healthcare, and public health.


Asunto(s)
Enfermedad de Alzheimer , Adulto , Humanos , Masculino , Femenino , Estudios Transversales , Encéfalo , Pruebas Neuropsicológicas , Sistema de Registros
2.
J Prev Alzheimers Dis ; 10(3): 551-561, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-37357297

RESUMEN

BACKGROUND: Failure of Alzheimer's disease and related diseases (ADRD) research studies to include and engage Black participants is a major issue, which limits the impact and generalizability of research findings. Little is known about participation of Black adults in online ADRD-related research registries. OBJECTIVES: As part of the Community Engaged Digital Alzheimer's Research (CEDAR) Study, this study aims to increase our understanding of facilitators and barriers of Black adults to participating in ADRD-related online registries, as well as to understand their preferences for communication channels. DESIGN, SETTING, PARTICIPANTS, MEASUREMENTS: We invited all Black participants enrolled in the Brain Health Registry (BHR) to complete a cross-sectional online survey. The survey consisted of rating scales and open-text questions asking about their attitudes towards brain health research, reasons for joining and continuing to participate in BHR, difficulties with participating, and preferences for modes of contact and website usage. RESULTS: Of all invited Black BHR participants (N=3,636), 198 (5.5%) completed the survey. The mean age was 58.4 (SD=11.3), mean years of education were 16.3 (SD=2.4), and 85.5% identified as female. Reported facilitators for joining and continuing to participate in BHR were personal interest (e.g., learning more about own brain health) and altruism (e.g., helping research). Among additional registry features which could encourage return, receiving feedback or scores about BHR tasks was rated the highest. Of those who found BHR participation difficult (21%), the most frequent reason was time burden. The most preferred way of receiving study information was via email. Participants reported that the websites that they used the most were YouTube and Facebook. DISCUSSION: The results of our study can inform the development of culturally-responsive registry features and engagement efforts to improve inclusion and participation of Black adults in online ADRD research. Providing participants with feedback about their registry performance and reducing the number of registry tasks are among the recommended strategies.


Asunto(s)
Enfermedad de Alzheimer , Sistema de Registros , Femenino , Humanos , Persona de Mediana Edad , Población Negra , Encéfalo , Estudios Transversales , Anciano , Negro o Afroamericano
3.
J Prev Alzheimers Dis ; 10(3): 607-614, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-37357303

RESUMEN

BACKGROUND: This study aims to understand whether and how participant characteristics (age, gender, education, ethnocultural identity) are related to their feedback about taking a remote, unsupervised, online cognitive assessment. METHODS: The Brain Health Registry is a public online registry which includes cognitive assessments. Multivariable ordinal regressions assessed associations between participant characteristics and feedback responses of older (55+) participants (N=11,553) regarding their Cogstate Brief Battery assessment experience. RESULTS: Higher age, secondary education or less, Latino identity, and female gender were associated with a poorer assessment experience; higher age and a non-White identity were associated with experiencing the assessment instructions as less clear; and higher age, non-White identity, and secondary education or less were associated with rating additional human support with the assessment as more useful. DISCUSSION: Our findings highlight the importance of improving the design and instructions of unsupervised, remote, online cognitive assessments to better suit the needs of diverse communities.


Asunto(s)
Encéfalo , Cognición , Humanos , Femenino , Retroalimentación , Sistema de Registros , Pruebas Neuropsicológicas , Cognición/fisiología
4.
J Prev Alzheimers Dis ; 7(2): 122-127, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32236401

RESUMEN

BACKGROUND: Effective and measurable participant recruitment methods are urgently needed for clinical studies in Alzheimer's disease. OBJECTIVES: To develop methods for measuring recruitment tactics and evaluating effectiveness. METHODS: Recruitment tactics for the Alzheimer's Disease Neuroimaging Initiative (ADNI3) were measured using web and phone analytics, campaign metrics and survey responses. RESULTS: A total of 462 new participants were enrolled into ADNI3 through recruitment efforts. We collected metrics on recruitment activities including 82,003 unique visitors to the recruitment website and 3,335 calls to study phone numbers. The recruitment sources that produced the most screening and enrollment included online advertisements, local radio and newspaper coverage and emails and referrals from registries. CONCLUSIONS: Analysis of recruitment activity obtained through tracking methods provided some insight for effective recruitment. ADNI3 can serve as an example of how a data-driven approach to centralized participant recruitment can be utilized to facilitate clinical research.


Asunto(s)
Enfermedad de Alzheimer/diagnóstico por imagen , Neuroimagen , Selección de Paciente , Publicidad/métodos , Investigación Biomédica/organización & administración , Humanos , Estudios Longitudinales , Estudios Observacionales como Asunto , Encuestas y Cuestionarios
5.
Antiviral Res ; 58(1): 81-7, 2003 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-12719010

RESUMEN

The aim of the study was to establish a murine model for sensitive screening of potential compounds with in vitro anti-influenza A virus activity. The evaluation in this in vivo model is based on semi-quantitative detection of viral RNA using one-step reverse transcriptase polymerase chain reaction (RT-PCR). After intranasal infection of fully-conscious mice with influenza A virus, the viral load of the respiratory tract tissues was investigated. Peaks were observed in the nasopharynx between Days 1 and 4, in the trachea on Day 4, and in the lungs between Days 4 and 7 post infection. The elimination of virus correlated with the appearance of specific serum antibodies. After 4 days of treatment with zanamivir, trachea and lungs revealed negative RT-PCR results, whereas viral load in the nasopharynx was significantly reduced. In conclusion, the virus spread in the described murine model is similar to upper respiratory tract infection with influenza virus in human. Viral load measurement by semi-quantitative detection of viral RNA allows rapid and sensitive screening of potential compounds with in vitro anti-influenza A virus activity.


Asunto(s)
Antivirales/farmacología , Virus de la Influenza A/genética , Infecciones por Orthomyxoviridae/tratamiento farmacológico , ARN Viral/análisis , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa/métodos , Animales , Anticuerpos Antivirales/sangre , Modelos Animales de Enfermedad , Femenino , Guanidinas , Pulmón/virología , Ratones , Ratones Endogámicos BALB C , Nasofaringe/virología , Infecciones por Orthomyxoviridae/virología , Piranos , ARN Viral/genética , Ácidos Siálicos/farmacología , Tráquea/virología , Zanamivir
6.
Intervirology ; 40(1): 15-21, 1997.
Artículo en Inglés | MEDLINE | ID: mdl-9268766

RESUMEN

The animal model of necrotic hepatitis caused by HSV-1 infection in juvenile mice was used to compare the efficacies of the oral antiherpes agents famciclovir (FCV), valaciclovir (VACV) and brivudin (BVDU). The experimental infection allows the measurement of viral replication in the liver by macroscopic lesions and the evaluation of mortality from encephalitis. Mice intravenously inoculated with a highly virulent clinical HSV-1 isolate were orally treated by gavage over a period of 3 days starting on day 2 post infection. The reference drug acyclovir (ACV) was administered subcutaneously. Necrotic hepatitis was significantly (p < 0.01) reduced by treatment with FCV, VACV and ACV at a dose of 50 mg/kg per day divided into 3 doses. No significant effect was achieved with BVDU at 200 mg/kg per day. Treatment with FCV at 50 mg/kg per day, ACV at 100 mg/kg per day, and VACV at 200 mg/kg per day significantly (p < 0.001) decreased mortality in mice. BVDU treatment at 200 mg/kg per day did not reduce mortality but significantly prolonged (p < 0.05) the survival time.


Asunto(s)
Antivirales/administración & dosificación , Herpes Zóster/tratamiento farmacológico , Herpesvirus Humano 1/fisiología , 2-Aminopurina/administración & dosificación , 2-Aminopurina/análogos & derivados , Aciclovir/administración & dosificación , Aciclovir/análogos & derivados , Animales , Bromodesoxiuridina/administración & dosificación , Bromodesoxiuridina/análogos & derivados , Línea Celular , Modelos Animales de Enfermedad , Famciclovir , Hepatitis Animal/virología , Hígado/patología , Hígado/virología , Ratones , Ratones Endogámicos BALB C , Valaciclovir , Valina/administración & dosificación , Valina/análogos & derivados , Ensayo de Placa Viral , Replicación Viral/efectos de los fármacos
8.
Antiviral Res ; 10(1-3): 99-106, 1988 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-2852923

RESUMEN

We investigated the influence of disodium phosphonic formate (PFA-Na2) and trisodium thiophosphonic formate (TPFA-Na3), in comparison with acyclovir (Zovirax) and trisodium phosphonic formate (PFA-Na3) (Triapten) ointment, on the course of primary cutaneous herpes simplex virus infection in a guinea pig skin model. PFA-Na2 at 3.0%, TPFA-Na3 at 0.5% and PFA-Na3 at 0.5% as well as Triapten ointment (2.0% PFA-Na3) completely inhibited virus infection. Zovirax cream (5.0% acyclovir), applied five times (15 min., 4, 20, 24, and 28 h) after virus inoculation did not prevent virus infection. Similarly, application of Zovirax cream 5 times daily for 5 days did not prevent a vesicle formation following cutaneous herpes simplex virus infection of the guinea pig.


Asunto(s)
Aciclovir/farmacología , Difosfatos/farmacología , Herpes Simple/tratamiento farmacológico , Simplexvirus/efectos de los fármacos , Enfermedades Cutáneas Infecciosas/tratamiento farmacológico , Aciclovir/uso terapéutico , Animales , Difosfatos/uso terapéutico , Femenino , Cobayas , Masculino
9.
Acta Virol ; 29(6): 493-8, 1985 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-2869661

RESUMEN

Clinical isolates of herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) induced focal necrotic hepatitis in ICR/Schö mice. The extent of the hepatitis could be considerably reduced by trisodium phosphonoformate (PFA) administered for 3 days in a daily dose of 400-600 mg/kg. The HSV hepatitis in mice could serve as a suitable model for testing antiherpetic drugs.


Asunto(s)
Antivirales/uso terapéutico , Hepatitis Viral Animal/tratamiento farmacológico , Herpes Simple/tratamiento farmacológico , Compuestos Organofosforados/uso terapéutico , Ácido Fosfonoacético/uso terapéutico , Animales , Modelos Animales de Enfermedad , Foscarnet , Hepatitis Viral Animal/patología , Herpes Simple/patología , Hígado/patología , Ratones , Necrosis , Ácido Fosfonoacético/análogos & derivados
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA